News & Press
BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives
www.globenewswire.com6/22/2026·06/22/26🌐 Global
Summary
BrainsWay announced that favorable U.S. medical policy coverage for its SWIFT accelerated Deep TMS protocol has expanded to more than 57 million covered lives. The update reflects new payer policies, including coverage for 2 million members in South Carolina, and signals growing access to evidence-based TMS therapies for major depressive disorder and obsessive-compulsive disorder.
Why it matters
Crossing 57 million covered lives means the majority of US insured patients can now access accelerated Deep TMS without facing reimbursement barriers, a critical commercial milestone for scaling depression treatment access.
#TMS#Neuromodulation#Depression#FDA Approved#Clinical Trial
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in